Cargando…
Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
BACKGROUND: Somatostatin receptor (SSTR) positron emission tomography (PET) is a cornerstone of neuroendocrine tumor (NET) management. Hybrid PET/magnetic resonance imaging (MRI) is now available for NET-imaging, next to PET/computed tomography (CT). OBJECTIVES: To determine whether CT or MRI is the...
Autores principales: | Lens, Géraldine, Ahmadi Bidakhvidi, Niloefar, Vandecaveye, Vincent, Grauwels, Steven, Laenen, Annouschka, Deckers, Wies, Peeters, Ronald, Dresen, Raphaëla C., Dekervel, Jeroen, Verslype, Chris, Nackaerts, Kristiaan, Clement, Paul M., Van Cutsem, Eric, Koole, Michel, Goffin, Karolien, Van Laere, Koen, Deroose, Christophe M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599114/ https://www.ncbi.nlm.nih.gov/pubmed/37885461 http://dx.doi.org/10.1177/17588359231189133 |
Ejemplares similares
-
Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023) -
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021) -
Value of [(68)Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature
por: Deleu, Anne-Leen, et al.
Publicado: (2022) -
Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms
por: Trikalinos, Nikolaos A., et al.
Publicado: (2022) -
Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
por: Ko, Andrew, et al.
Publicado: (2021)